Legal & General Group
NAGE

Legal & General Group’s Niagen Bioscience NAGE Stock Holding History

Legal & General Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Sell
6,271
-6,069
-49% -$24.6K ﹤0.01% 3117
2026
Q1 		$54.4K Sell
12,340
-46,744
-79% -$252K ﹤0.01% 2670
2025
Q4 		$376K Sell
59,084
-152
-0.3% -$1.06K ﹤0.01% 2489
2025
Q3 		$553K Sell
59,236
-8,862
-13% -$89.5K ﹤0.01% 2425
2025
Q2 		$981K Buy
68,098
+62,871
+1,203% +$621K ﹤0.01% 2246
2025
Q1 		$36.1K Hold
5,227
– – ﹤0.01% 2770
2024
Q4 		$27.7K Sell
5,227
-199
-4% -$1.09K ﹤0.01% 2914
2024
Q3 		$19.8K Hold
5,426
– – ﹤0.01% 3053
2024
Q2 		$14.9K Buy
+5,426
New +$18.2K ﹤0.01% 3147
2022
Q3 		– Sell
-3,744
Closed -$6K – 3497
2022
Q2 		$6K Sell
3,744
-1,134
-23% -$2.22K ﹤0.01% 3436
2022
Q1 		$12K Hold
4,878
– – ﹤0.01% 3371
2021
Q4 		$18K Hold
4,878
– – ﹤0.01% 3315
2021
Q3 		$31K Hold
4,878
– – ﹤0.01% 3121
2021
Q2 		$48K Buy
4,878
+481
+11% +$4.19K ﹤0.01% 2965
2021
Q1 		$41K Sell
4,397
-582
-12% -$4.61K ﹤0.01% 2886
2020
Q4 		$24K Hold
4,979
– – ﹤0.01% 3025
2020
Q3 		$20K Sell
4,979
-2,018
-29% -$9.73K ﹤0.01% 2975
2020
Q2 		$32K Buy
6,997
+9
+0.1% +$40 ﹤0.01% 2867
2020
Q1 		$23K Sell
6,988
-1,716
-20% -$6.59K ﹤0.01% 2865
2019
Q4 		$38K Buy
8,704
+2,976
+52% +$10.6K ﹤0.01% 2933
2019
Q3 		$23K Hold
5,728
– – ﹤0.01% 3093
2019
Q2 		$27K Hold
5,728
– – ﹤0.01% 3085
2019
Q1 		$24K Hold
5,728
– – ﹤0.01% 3035
2018
Q4 		$20K Hold
5,728
– – ﹤0.01% 3087
2018
Q3 		$25K Hold
5,728
– – ﹤0.01% 3123
2018
Q2 		$21K Buy
+5,728
New +$21.8K ﹤0.01% 3181
2017
Q2 		– Sell
-4,744
Closed -$13K – 3389
2017
Q1 		$13K Buy
4,744
+1,962
+71% +$5.56K ﹤0.01% 3163
2016
Q4 		$9K Buy
+2,782
New +$7.56K ﹤0.01% 3231

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Legal & General Group's NAGE Position: Q2 2026 in Review

Legal & General Group reduced its Niagen Bioscience (NAGE) stake by 49% in Q2 2026, selling an estimated $24.6K and leaving 6,271 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #3117.

Legal & General Group first reported a position in NAGE in Q4 2016 and has held it in 28 quarters since. The position peaked at $981K in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Legal & General Group held 6,271 shares of Niagen Bioscience worth $20K as of Q2 2026.
  • Legal & General Group sold 6,069 Niagen Bioscience shares in Q2 2026, an estimated $24.6K.
  • Niagen Bioscience made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3117 holding.
  • Legal & General Group first reported a position in Niagen Bioscience in Q4 2016 and has held it in 28 quarters since.
  • Legal & General Group's Niagen Bioscience position peaked at $981K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.